Skip to content

Inspire hope.
Restore life.
Purpose-built to attack cancer.

Leadership Founders Board of Directors Scientific Advisory Board

Targeted radiotherapeutics hold the potential to transform the treatment of cancer, but the ability to finely tune radioisotope delivery, while sparing healthy tissue, remains a major challenge. Abdera is leveraging its proprietary ROVEr™ platform to engineer and develop new precision radiotherapeutics with tunable PK properties to maximize therapeutic effect while mitigating systemic toxicities in order to treat a broad range of solid tumors.

Our company, technology and team are purpose-built to attack cancer.

We are led by a dynamic team of scientists and company builders with deep know-how and experience spanning oncology, radiopharmaceuticals and biologics. We share a passion for innovative science and are united in our pursuit to develop better, optimized therapies for people living with cancer.

Leadership

Partners & Investors